Bone Biologics Corp - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bone Biologics Corporation on March 15, 2016, reporting events occurring on March 14, 2016. The filing primarily addresses the entry into a material definitive agreement regarding the separation of a senior executive.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the specific compensation terms of the executive separation agreement:
- Base Salary: $300,000 annualized rate, to be paid in installments.
- Transition Expenses: $2,500.
- New Stock Options: 54,000 shares fully vested at an exercise price of $2.05 per share.
- Existing Options Extension: Term extended for 799,414 shares.
Material Changes
The primary material change is the resignation of William Jay Treat as Chief Technology Officer, effective retroactively to March 1, 2016. This change was formalized through a Separation Agreement entered into on March 14, 2016.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of general risks and contingencies beyond the execution of the separation agreement. The unusual item noted is the specific grant of fully vested options and the extension of existing option terms as part of the severance package.
Key Facts for Investor Verification
- Confirm the effective date of the CTO resignation (March 1, 2016) versus the agreement date (March 14, 2016).
- Verify the total number of shares subject to options (54,000 new + 799,414 existing) and the extended expiration date of February 16, 2021.
- Assess the impact of the $300,000 annualized salary continuation and $2,500 transition expense on the company's immediate cash burn.
- Review the attached Separation Agreement (Exhibit 10.1) for any additional non-disclosure or non-compete clauses not summarized in the text.